Neurotherapeutic Program Aims to Improve Motor, Cognitive Functions
MindMaze is partnering with Mount Sinai Health System in New York to accelerate the access of people with…
Andrea Lobo is a Science writer at BioNews. She holds a Biology degree and a PhD in Cell Biology/Neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. She was a postdoctoral and senior researcher at the Institute for Research and Innovation in Health in Porto, in drug addiction, studying neuronal plasticity induced by amphetamines. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She authored multiple research papers in peer-reviewed journals. She shifted towards a career in science writing and communication in 2022.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
MindMaze is partnering with Mount Sinai Health System in New York to accelerate the access of people with…
Aggression aimed at caregivers in Parkinson’s disease and related disorders is associated with patients’ grief in coping with disease…
Treatment with DopaFuse, a continuous oral levodopa-carbidopa delivery system being developed by SynAgile, was safe and lessened motor…
Dental care often is irregular in people with Parkinson’s disease, who also require more dental treatments that those without…
People who had COVID-19 might have an increased risk for developing neurodegenerative diseases, such as Parkinson’s disease, researchers in…
Neural implants combining artificial intelligence with microelectronics could directly modulate the brain’s activity to help treat brain disorders, including…
New York University Langone Health is collaborating with the Michael J. Fox Foundation for Parkinson’s Research in the Parkinson’s…
A research team at the Icahn School of Medicine at Mount Sinai, New York has won the 2022…
CENTOGENE has announced it’s reached a milestone of 12,500 participants who have been recruited and genetically tested as part…
Older age at onset, more severe motor symptoms, and cognitive impairment are risk factors for the progression of gait and…
Get regular updates to your inbox.